vBMD and bone structure parameters by HRpQCT at the nondominant ultradistal radius in MGUS patients and control subjects
| . | MGUS . | Control . | Pr > t* . |
|---|---|---|---|
| Bone area, mm2 | 319.9 ± 12.5 | 294.1 ± 7.4 | .004 |
| Cortical area, mm2 | 60.9 ± 2.7 | 64.9 ± 2.0 | .120 |
| Endocortical area, mm2 | 252.2 ± 11.4 | 224.0 ± 6.6 | .003 |
| Averge vBMD, mg HA/cm3 | 300.1 ± 10.1 | 334.9.0 ± 7.2 | .005 |
| Trabecular vBMD, mg HA/cm3 | 149.9 ± 5.8 | 160.9 ± 4.0 | .080 |
| Cortical vBMD, mg HA/cm3 | 822.2 ± 11.8 | 862.4 ± 6.9 | .001 |
| Cortical thickness, mm | 0.80 ± 0.03 | 0.88 ± 0.02 | .029 |
| Trabecular bone volume/tissue volume | 0.125 ± 0.005 | 0.134 ± 0.003 | .080 |
| No. of trabeculae, 1/mm | 1.82 ± 0.05 | 1.81 ± 0.03 | .895 |
| Trabecular thickness, mm | 0.068 ± 0.002 | 0.074 ± 0.001 | .004 |
| Trabecular separation, mm | 0.518 ± 0.030 | 0.501 ± 0.015 | .547 |
| SD of trabecular separation, mm | 0.258 ± 0.025 | 0.231 ± 0.012 | .273 |
| . | MGUS . | Control . | Pr > t* . |
|---|---|---|---|
| Bone area, mm2 | 319.9 ± 12.5 | 294.1 ± 7.4 | .004 |
| Cortical area, mm2 | 60.9 ± 2.7 | 64.9 ± 2.0 | .120 |
| Endocortical area, mm2 | 252.2 ± 11.4 | 224.0 ± 6.6 | .003 |
| Averge vBMD, mg HA/cm3 | 300.1 ± 10.1 | 334.9.0 ± 7.2 | .005 |
| Trabecular vBMD, mg HA/cm3 | 149.9 ± 5.8 | 160.9 ± 4.0 | .080 |
| Cortical vBMD, mg HA/cm3 | 822.2 ± 11.8 | 862.4 ± 6.9 | .001 |
| Cortical thickness, mm | 0.80 ± 0.03 | 0.88 ± 0.02 | .029 |
| Trabecular bone volume/tissue volume | 0.125 ± 0.005 | 0.134 ± 0.003 | .080 |
| No. of trabeculae, 1/mm | 1.82 ± 0.05 | 1.81 ± 0.03 | .895 |
| Trabecular thickness, mm | 0.068 ± 0.002 | 0.074 ± 0.001 | .004 |
| Trabecular separation, mm | 0.518 ± 0.030 | 0.501 ± 0.015 | .547 |
| SD of trabecular separation, mm | 0.258 ± 0.025 | 0.231 ± 0.012 | .273 |
HA indicates hydroxyapatite.
P values are adjusted for age and sex.